최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
DataON 바로가기다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
Edison 바로가기다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
Kafe 바로가기국가/구분 | United States(US) Patent 등록 |
---|---|
국제특허분류(IPC7판) |
|
출원번호 | US-0683396 (2007-03-07) |
등록번호 | US-8409131 (2013-04-02) |
발명자 / 주소 |
|
출원인 / 주소 |
|
대리인 / 주소 |
|
인용정보 | 피인용 횟수 : 6 인용 특허 : 1650 |
An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing
An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.
1. An integrated therapy management device, comprising: a housing comprising: a receiver unit configured to receive one or more signals related to an analyte level from an analyte sensor;a data controller in communication with the receiver unit and configured to process the one or more signals relat
1. An integrated therapy management device, comprising: a housing comprising: a receiver unit configured to receive one or more signals related to an analyte level from an analyte sensor;a data controller in communication with the receiver unit and configured to process the one or more signals related to the analyte level to determine a dose of a desired medicant; anda drug administration system in communication with the data controller to deliver the dose of the desired medicant, the drug administration system being part of a drug delivery system that is configured to determine a drug sensitivity feedback based on the one or more signals related to the analyte level; anda display coupled to the housing and configured to display data related to one or more of the determined dose of the desired medicant, the delivered dose of the desired medicant, or the analyte level; wherein the data controller, the receiver unit and the drug administration system are integrated as a single unit in the housing;wherein the data controller is configured to tag the one or more signals which are related to an episode of hyperglycemic condition or hypoglycemic condition for use in a data analysis of the episode of hyperglycemic condition or hypoglycemic condition;wherein the data controller is trainable such that the data controller is configured to analyze the tagged data associated with the episode of hyperglycemic condition or hypoglycemic condition to determine one or more patterns associated with the one or more of the hyperglycemic or hypoglycemic conditions, to determine the one or more patterns in response to the delivered medicant and the one or more signals related to the analyte level, and to provide a drug administration protocol based on the determined one or more patterns in response to the delivered medicant and the one or more signals related to the analyte level; and furtherwherein the drug administration system is configured to deliver a modified dose of desired medicant based upon the one or more patterns of the one or more of the hyperglycemic or hypoglycemic conditions determined by the data controller. 2. The device of claim 1, wherein the receiver unit includes one of a transmitter, a receiver, or a transceiver. 3. The device of claim 1 wherein the drug administration system is an insulin delivery unit. 4. The device of claim 3 wherein the insulin delivery unit includes an external infusion pump. 5. The device of claim 1 wherein the display is configured to display therapy related data. 6. The device of claim 5 wherein the therapy related data includes one or more monitored analyte level or the drug administration protocol. 7. The system of claim 1 wherein the drug delivery system is configured to provide an on-going drug sensitivity feedback. 8. The system of claim 1 wherein the drug administration system modifies the dose of the desired medicant based on the drug sensitivity feedback. 9. The system of claim 1 wherein the drug sensitivity feedback is based at least in part on the one or more signals associated with the received analyte level. 10. The device of claim 1 wherein the data controller is configured to determine a characteristic time constant based upon the one or more signals related to the analyte level and the delivered dose of the desired medicant, and to modify the drug administration protocol based upon the characteristic time constant. 11. The device of claim 10 wherein the drug administration protocol is modified in real-time. 12. The device of claim 10 wherein the drug administration protocol is modified at a future time. 13. The device of claim 1 wherein the data controller is configured to receive data associated with the episode of hyperglycemic condition or hypoglycemic condition from an input unit. 14. A computer-implemented method, comprising: receiving, at a receiver unit, one or more signals related to an analyte level from an analyte sensor;processing, using a data controller in communication with the receiver unit, the one or more signals related to the analyte level to determine a dose of a desired medicant;delivering, using a drug administration system in communication with the data controller, the dose of the desired medicant, wherein the drug administration system is part of a drug delivery system;determining, using the drug delivery system, a drug sensitivity feedback based on the one or more signals related to the analyte level; anddisplaying, using a display, data related to one or more of the determined dose of the desired medicant, the delivered dose of the desired medicant, or the analyte level; wherein the receiver unit, the data controller, and the drug administration system are integrated as a single unit in a housing, and the display is coupled to the housing;wherein the one or more signals which are related to an episode of hyperglycemic condition or hypoglycemic condition are tagged, using the data controller, for use in a data analysis of the episode of hyperglycemic condition or hypoglycemic condition;wherein the data controller is trainable such that the tagged data associated with the episode of hyperglycemic condition or hypoglycemic condition is analyzed, using the data controller, to determine one or more patterns associated with the one or more of the hyperglycemic or hypoglycemic conditions, to determine the one or more patterns in response to the delivered medicant and the one or more signals related to the analyte level, and to provide a drug administration protocol based on the determined one or more patterns in response to the delivered medicant and the one or more signals related to the analyte level;wherein a modified dose of the desired medicant is delivered, using the drug administration system, based upon the determined one or more patterns of the one or more of the hyperglycemic or hypoglycemic conditions. 15. The method of claim 14 further including displaying therapy related data including the drug administration protocol. 16. The method of claim 14 further including providing an on-going drug sensitivity feedback. 17. The method of claim 14 wherein the drug sensitivity feedback is based at least in part on the one or more signals associated with the received analyte level. 18. The method of claim 14 further including determining a characteristic time constant based upon the one or more signals related to the analyte level and the delivered dose of the desired medicant, and modifying the drug administration protocol based upon the characteristic time constant. 19. The method of claim 18 wherein the drug administration protocol is modified in real-time. 20. The method of claim 18 wherein the drug administration protocol is modified at a future time.
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.